Re: BIOWARFARE

From: Kerry (kerryk12_at_askmefirsthotmail.com)
Date: 03/13/05 

Date: Sun, 13 Mar 2005 17:29:10 -0500

Hey, you are all cross posting again :(

Kerry

"kathleen" <kathleen.dickson@snet.net> wrote in message
news:1110717475.758257.97170@g14g2000cwa.googlegroups.com...
> http://www.emedicinehealth.com/articles/15704-3.asp
>
> "It has been considered an important biological warfare agent because
> it can infect many people if dispersed by the aerosol route."
>
> That's the connection- Vector borne diseases are often the same thing
> as bioweapons because of their environmental sturdiness and
> aerosolizability. The spirochetes leptospira is definitely
> aerosolizable, and UNSCOM was looking for tick nurseries in Iraq.
>
> The reality is that vector borne diseases have evolved faster than
> scientists have masterminded them.
>
>
> Of course, the bad guys of Lyme say these gemmae/spherical bodies (cyst
> forms) do not exist, but here is Barbour describing them:
>
> "They attach randomly to all surfaces of the spirochete, ie., to the
> aneurysmic blebs, gemmae, or spherical bodies, or to the outermost tip
> of the cell."
>
> http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=217620&blobtype=pdf
>
> And that is the mechanism of evolution of virulence factors among
> pathogens in vectors.
>
> It is likely that these gemmae and spherical bodies that are the
> aerosolized/weaponized form (that is, they occur naturally). They are
> also called starvation forms.
>
> http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Display&dopt=pubmed_pubmed&from_uid=12422604
>
> Our own UCONN's Justin Radolf studies these things.
>
> But what explains the chronic denial of the existance of chronic Lyme?
> Klempner went out of his way to say Chronic Lyme was not like
> tuberculosis- a chronic infection, when in fact, Lyme is very much like
> tuberculosis, via the lipidated (slymy) Osps, and of course, the OspA
> vaccine- which was immune-suppressing.
>
> Oddly, the bad guys of Lyme insist these are immune stimulating
> antigens and now want to use them as vaccine adjuvants (Persing and
> Corixa). Lyme is defined by NIAID as an inflammatory disease, when in
> fact, it is the opposite in the majority of the cases.
>
> Allergy and Infectious Disease- they are the same dynamic.
>
> Lyme arthritis is rare.
>
> And so the current explainer on politically burying Lyme as the
> epidemic that it is (masquerading as CFIDS/FM/MS, dementia, Depression,
> etc), that the epidemic is *SO* huge. And you can verify
> independently, just by visiting the DHHS's website on contamination of
> the blood supply by infections, especially chagas, which is never ruled
> out in chronic Lyme, although all the primary mammalian hosts, deer and
> mice, are loaded with trypanosomes, for example.
>
> And so, if a person was NOT a deranged NIH "awfully damned intelligent"
> microbiologist who fantasizes all day long about bioweapons outbreaks,
> when he/she is not fussing on the Lyme newsgroup, he/she would be
> looking at who is developing what antibiotics. It makes no logical
> sense to be spending so much time on bioweapons, when most are either
> treatable, or you die from them, and the lingering greater cost, is in
> Lyme, which is a slow, excruciating death. And it would have made no
> sense to use Lyme as a bioweapon, because as such a chronic disabler,
> it
> can be diagnosed. Contrary to what we are told.
>
>
> I don't even think it really matters if Lyme was a Plum Island
> accidental release. However, the concept of a chronic disabler, is
> indeed costly, but Borrelia are on every continent- the new great
> equalizer. And via this mechanism of bacteriophage-vectored lateral
> transfer and transkingdom transfer of virulence determinants, the
> epidemic is out of control, to an exponential degree.
>
> Alan Barbour:
> http://www.nature.com/cgi-taf/DynaPage.taf?file=/nature/journal/v390/n6660/full/390553a0_fs.html
>
> "The results encourage study of a more metabolically competent
> spirochaete, such as the free-living Spirochaeta aurantia, for a better
> understanding of how this ancient group of bacteria evolved, and to
> identify catalytic molecules of industrial importance."
>
> "identify catalytic molecules of industrial importance?"
>
> That isn't what he meant, as an Epidemiological Intelligence Office of
> the CDC. What Barbour went after next was the porins
> (can be toxic and lytic- can kill cells, or be a port that exudes
> toxins)like P66.
>
> Donta patented the one neurotoxin borrelia exudes, that we know of to
> date. And Donta is pretty familiar with bacterial toxins.
> http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=donta%20st%5BAuthor%5D
>
> 80 publications
>
>
> Other enzymes can be lytic of course.
> And an enzyme is an enzyme. They can disrupt normal host processes,
> and that would be the nature of a parasitic disease.
>
> John Dunn at Brookhaven (Department of Defense) says Lyme is a stealth
> pathogen.
> http://www.bnl.gov/world/
>
>
> So, it makes no rational sense to bury Lyme disease. All the rest of
> the pathogens and bioweapons agents are to some degree managable
> because they are so much simpler.
>
> And NOT the NIH and NOT NIH and CDC interest-conflicted scientists, and
> NOT Congressmen should be deciding where research dollars go, but the
> PEOPLE should be deciding what we want.
>
>
> The only problem is, the bad guys fudge the numbers, ie, the CDC has
> this bogus Lyme test of Allen Steere's:
> http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5405a6.htm
>
> The public needs to be cautioned that the CDC's test is flagrantly and
> abundantly bogus, and I can't comment here on the other tests they
> discuss. Russell Johnson certainly thought urine antigen testing was
> reasonable. He did it himself.
>
> The very fact that there is a "controversy" over Lyme should raise
> suspicions, because there was a "controversy" over Big Tobacco and
> whether or not nicotine was addictive. It was my understanding that
> tobacco companies were spiking cigarettes with nicotine, while
> simultaneously denying nicotine was addictive.
> I could be wrong.
>
> Besides, nicotine is not what drives tobacco addiction.
>
> Like everything else they dabble in, these Psychiatrists don't know
> what they are talking about, since none of psychiatry is scientific,
> other than what the drug companies tell them.
> And what they *don't* tell them, is proprietary data, and that all
> psychoactives are neurotoxic.
>
> Lithium is a salt and a natural element, that stabilizes membranes and
> is neuroprotective. The only problem with Lithium, is that no one can
> patent it.
>
>
> J Clin Psychiatry. 2000;61 Suppl 9:82-96. Related Articles, Links
>
> Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in
> vivo: a role for neurotrophic and neuroprotective effects in manic
> depressive illness.
>
> Manji HK, Moore GJ, Chen G.
>
> Department of Psychiatry & Behavioral Neurosciences, Wayne State
> University School of Medicine, Detroit, Mich 48201, USA.
> hmanji@med.wayne.edu
>
> Although mood disorders have traditionally been conceptualized as
> "neurochemical disorders," considerable literature from a variety of
> sources demonstrates significant reductions in regional central nervous
> system (CNS) volume and cell numbers (both neurons and glia) in persons
> with mood disorders. It is noteworthy that recent advances in cellular
> and molecular biology have resulted in the identification of 2 novel,
> hitherto completely unexpected targets of lithium's actions,
> discoveries that may have a major impact on the future use of this
> unique cation in biology and medicine. Chronic lithium treatment has
> been demonstrated to markedly increase the levels of the major
> neuroprotective protein bc1-2 in rat frontal cortex, hippocampus, and
> striatum. Similar lithium-induced increases in bc1-2 are also observed
> in cells of human neuronal origin and are observed in rat frontal
> cortex at lithium levels as low as approximately 0.3 mM. Bc1-2 is
> widely regarded as a major neuroprotective protein, and genetic
> strategies that increase bc1-2 levels have demonstrated not only robust
> protection of neurons against diverse insults, but have also
> demonstrated an increase in the regeneration of mammalian CNS axons.
> Lithium has also been demonstrated to inhibit glycogen synthase kinase
> 3beta (GSK-3beta), an enzyme known to regulate the levels of
> phosphorylated tau and beta-catenin (both of which may play a role in
> the neurodegeneration observed in certain forms of Alzheimer's
> disease). Consistent with the increases in bc1-2 levels and inhibition
> of GSK-3beta, lithium has been demonstrated to exert robust protective
> effects against diverse insults both in vitro and in vivo. These
> findings suggest that lithium may exert some of its long-term
> beneficial effects in the treatment of mood disorders via
> underappreciated neurotrophic and neuroprotective effects. To date,
> lithium remains the only medication demonstrated to markedly increase
> bc1-2 levels in several brain areas; in the absence of other adequate
> treatments, an investigation of the potential efficacy of lithium in
> the long-term treatment of several neurodegenerative disorders is
> warranted. Additionally, we suggest that a reconceptualization of the
> use of lithium in mood disorders may be warranted-namely, that the use
> of lithium as a neurotrophic/neuroprotective agent should be considered
> in the long-term treatment of mood disorders, irrespective of the
> "primary" treatment modality being used for the condition.
>
> MID: 10826666 [PubMed - indexed for MEDLINE]
>
>
> Note that you never see a Psychiatrist, or NAMI, or the APA involved in
> the development of nerve agent antidotes, or brain
> surgery, or stem cell transplants for Parkinson's, or the development
> that is anything helpful for any brain condition.
>
> This is what they are good for:
> http://pn.psychiatryonline.org/cgi/content/full/40/3/4?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&searchid=1110717172826_1289&stored_search=&FIRSTINDEX=0&minscore=5000&journalcode=psychnews
>
>
> "Whores for the courts."
>
> Kathleen
>

Quantcast